3/2
04:31 pm
aneb
Form 15-12G Anebulo Pharmaceuticals,
High
Report
Form 15-12G Anebulo Pharmaceuticals,
2/17
04:53 pm
aneb
Form 25 Anebulo Pharmaceuticals,
Low
Report
Form 25 Anebulo Pharmaceuticals,
2/13
05:01 pm
aneb
Form SCHEDULE 13G/A Anebulo Pharmaceuticals, Filed by: Nantahala Capital Management, LLC
Low
Report
Form SCHEDULE 13G/A Anebulo Pharmaceuticals, Filed by: Nantahala Capital Management, LLC
2/12
04:31 pm
aneb
Form 10-Q Anebulo Pharmaceuticals, For: Dec 31
Low
Report
Form 10-Q Anebulo Pharmaceuticals, For: Dec 31
2/12
04:16 pm
aneb
Form 8-K Anebulo Pharmaceuticals, For: Feb 12
Low
Report
Form 8-K Anebulo Pharmaceuticals, For: Feb 12
2/6
09:20 am
aneb
Form 8-K Anebulo Pharmaceuticals, For: Feb 05
High
Report
Form 8-K Anebulo Pharmaceuticals, For: Feb 05
1/29
09:20 am
aneb
Form SC TO-I/A Anebulo Pharmaceuticals, Filed by: Anebulo Pharmaceuticals, Inc.
Low
Report
Form SC TO-I/A Anebulo Pharmaceuticals, Filed by: Anebulo Pharmaceuticals, Inc.
1/29
09:15 am
aneb
Form 8-K Anebulo Pharmaceuticals, For: Jan 29
Low
Report
Form 8-K Anebulo Pharmaceuticals, For: Jan 29
1/27
09:29 am
aneb
Form SC TO-I/A Anebulo Pharmaceuticals, Filed by: Anebulo Pharmaceuticals, Inc.
Medium
Report
Form SC TO-I/A Anebulo Pharmaceuticals, Filed by: Anebulo Pharmaceuticals, Inc.
1/27
09:25 am
aneb
Form 8-K Anebulo Pharmaceuticals, For: Jan 26
Medium
Report
Form 8-K Anebulo Pharmaceuticals, For: Jan 26
1/8
09:21 am
aneb
Form SC TO-I/A Anebulo Pharmaceuticals, Filed by: Anebulo Pharmaceuticals, Inc.
Low
Report
Form SC TO-I/A Anebulo Pharmaceuticals, Filed by: Anebulo Pharmaceuticals, Inc.
12/22
05:26 pm
aneb
Form SC TO-I Anebulo Pharmaceuticals, Filed by: Anebulo Pharmaceuticals, Inc.
High
Report
Form SC TO-I Anebulo Pharmaceuticals, Filed by: Anebulo Pharmaceuticals, Inc.
12/22
09:07 am
aneb
Form SC TO-I Anebulo Pharmaceuticals, Filed by: Anebulo Pharmaceuticals, Inc.
High
Report
Form SC TO-I Anebulo Pharmaceuticals, Filed by: Anebulo Pharmaceuticals, Inc.
12/22
09:00 am
aneb
Form 8-K Anebulo Pharmaceuticals, For: Dec 22
High
Report
Form 8-K Anebulo Pharmaceuticals, For: Dec 22